Stevers, Loes M. http://orcid.org/0000-0002-5080-2955
Wolter, Madita
Carlile, Graeme W.
Macdonald, Dwight http://orcid.org/0000-0002-6838-7905
Richard, Luc http://orcid.org/0000-0002-0494-8179
Gielkens, Frank
Hanrahan, John W.
Thomas, David Y.
Chakka, Sai Kumar
Peterson, Mark L. http://orcid.org/0000-0002-5647-3275
Thomas, Helmut
Brunsveld, Luc http://orcid.org/0000-0001-5675-511X
Ottmann, Christian http://orcid.org/0000-0001-7315-0315
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (675179)
Article History
Received: 12 June 2021
Accepted: 7 June 2022
First Online: 23 June 2022
Competing interests
: L.B. and C.O. are founders and shareholders of Ambagon Therapeutics, C.O. and L.M.S. are employees of Ambagon Therapeutics. The remaining authors declare no competing interests.